Variability of platelet-rich plasma preparations

Sports Medicine and Arthroscopy Review

Volumn 21, Issue 4, 2013, Pages 186-190

  Russell, Ryan P ^a   Apostolakos, John ^a   Hirose, Toshiaki ^a   Cote, Mark P ^a   Mazzocca, Augustus D ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

centrifugation; growth factors; leukocytes; platelet rich plasma; platelets; variability

Indexed keywords

ANESTHETIC AGENT; CORTICOSTEROID;

BLOOD AUTOTRANSFUSION; BONE INJURY; CARTILAGE INJURY; HUMAN; MUSCLE INJURY; PLASMA TRANSFUSION; PRIORITY JOURNAL; REVIEW; TENDON INJURY; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

ATHLETIC INJURIES; BIOLOGICAL MARKERS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTE COUNT; LEUKOCYTES; PLATELET-RICH PLASMA; WOUND HEALING;

EID: 84888248115     PISSN: 10628592     EISSN: 15381951     Source Type: Journal    
DOI: 10.1097/JSA.0000000000000007     Document Type: Review

References (47)

1. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: The state of play. Br J Sports Med. 2008;42:314-320
2. Maffulli N, Del Buono A. Platelet plasma rich products in musculoskeletal medicine: Any evidence? Surgeon. 2012;10: 148-150
3. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91:4-15
4. Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med. 2009;37:2259-2272
5. Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Plateletrich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308-316
6. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: The PAW classification system. Arthroscopy. 2012;28:998-1009
7. Cheung EV, Silverio L, Sperling JW. Strategies in biologic augmentation of rotator cuff repair: A review. Clin Orthop Relat Res. 2010;468:1476-1484
8. Garcia-Martinez O, Reyes-Botella C, Diaz-Rodriguez L, et al. Effect of platelet-rich plasma on growth and antigenic profile of human osteoblasts and its clinical impact. J Oral Maxillofac Surg. 2012;70:1558-1564
9. Cho HS, Song IH, Park SY, et al. Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med. 2011;31:212-218
10. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest. 2005;115:3339-3347
11. Deutsch VR, Tomer A. Megakaryocyte development and platelet production. Br J Haematol. 2006;134:453-466
12. Chang Y, Bluteau D, Debili N, et al. From hematopoietic stem cells to platelets. J Thromb Haemost. 2007;5(suppl 1):318-327
13. Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J. 2010;74:597-607
14. Cimmino G, Golino P. Platelet biology and receptor pathways. J Cardiovasc Transl Res. 2013;6:299-309
15. Lopez-Vilchez I, Galan AM, Hernandez MR, et al. Plateletassociated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro. Thromb Res. 2012;130:e294-e300
16. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: Growth factor content and roles in wound healing. J Dent Res. 2005;84:434-439
17. Boswell SG, Cole BJ, Sundman EA, et al. Platelet-rich plasma: A milieu of bioactive factors. Arthroscopy. 2012;28:429-439
18. Browning SR, Weiser AM, Woolf N, et al. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. J Bone Joint Surg Am. 2012;94:e1721-e1727
19. Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585-601
20. Moojen DJ, Everts PA, Schure RM, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008;26:404-410
21. Castillo TN, Pouliot MA, Kim HJ, et al. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39:266-271
22. Werther K, Christensen IJ, Nielsen HJ. Determination of vascular endothelial growth factor (VEGF) in circulating blood: Significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest. 2002;62:343-350
23. Lopez-Vidriero E, Goulding KA, Simon DA, et al. The use of platelet-rich plasma in arthroscopy and sports medicine: Optimizing the healing environment. Arthroscopy. 2010;26:269-278
24. Arnoczky S, Delos D, Rodeo S. What is platelet-rich plasmäOper Tech Sports Med. 2011;19:7
25. Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc Biol. 2013;93:875-881
26. Chang MY, Chan CK, Braun KR, et al. Monocyte-tomacrophage differentiation: Synthesis and secretion of a complex extracellular matrix. J Biol Chem. 2012;287: 14122-14135
27. Pauly S, Klatte F, Strobel C, et al. Characterization of tendon cell cultures of the human rotator cuff. Eur Cell Mater. 2010;20:84-97
28. Anitua E, Sanchez M, Orive G, et al. Shedding light in the controversial terminology for platelet rich products. J Biomed Mater Res A. 2009;90:1262-1263
29. Ranly DM, McMillan J, Keller T, et al. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am. 2005; 87:2052-2064
30. Nikolidakis D, Jansen JA. The biology of platelet-rich plasma and its application in oral surgery: Literature review. Tissue Eng Part B Rev. 2008;14:249-258
31. Marx RE. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent. 2001;10:225-228
32. Mazzucco L, Balbo V, Cattana E, et al. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang. 2009;97: 110-118
33. Wiens L, Lutze G, Luley C, et al. Platelet count and platelet activation: Impact of a fat meal and day time. Platelets. 2007;18:171-173
34. Tidball JG. Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc. 1995;27:1022-1032
35. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158-167
36. Han B, Woodell-May J, Ponticiello M, et al. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am. 2009;91:1459-1470
37. Ortel TL, Mercer MC, Thames EH, et al. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg. 2001;233:88-96
38. Sands JJ, Nudo SA, Ashford RG, et al. Antibodies to topical bovine thrombin correlate with access thrombosis. Am J Kidney Dis. 2000;35:796-801
39. Lawson JH. The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost. 2006;32(suppl 1): 98-110
40. Harrison S, Vavken P, Kevy S, et al. Platelet activation by collagen provides sustained release of anabolic cytokines. Am J Sports Med. 2011;39:729-734
41. Di Lullo GA, Sweeney SM, Korkko J, et al. Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem. 2002;277:4223-4231
42. Lacoste E, Martineau I, Gagnon G. Platelet concentrates: Effects of calcium and thrombin on endothelial cell proliferation and growth factor release. J Periodontol. 2003;74: 1498-1507
43. Wasterlain AS, Braun HJ, Dragoo JL. Contents and formulations of platelet-rich plasma. Oper Tech Orthop. 2012; 22:33-42
44. Alsousou J, Thompson M, Hulley P, et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: A review of the literature. J Bone Joint Surg Br. 2009;91:987-996
45. Spang JT, Tischer T, Salzmann GM, et al. Platelet concentrate vs. saline in a rat patellar tendon healing model. Knee Surg Sports Traumatol Arthrosc. 2011;19:495-502
46. Zimmermann R, Arnold D, Strasser E, et al. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang. 2003;85:283-289
47. Weibrich G, Kleis WK, Hafner G, et al. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res. 2003;14:357-362